Path to a Healthy Sleep with Sleep Apnea Devices

What Causes the sleep apnea?

Sleep apnea is caused by a blockage of the airway, usually when the soft tissue in the back of the throat collapses during sleep. This can be due to anatomical issues such as enlarged tonsils, a large tongue, or a narrow airway. Other risk factors include being overweight, smoking, drinking alcohol, and using certain sedatives or tranquilizers.

Major Growth Influencing Factors:

The global sleep apnea devices market is expected to witness significant growth in the coming years due to the increasing prevalence of sleep apnea and rising awareness of its treatment. The market is driven by the increasing adoption of sleep apnea devices, technological advancements in products, and the rising prevalence of sleep apnea. In addition, the rising healthcare expenditure and the increasing focus on preventive healthcare are also driving the growth of this market.

However, the high cost of sleep apnea devices, lack of reimbursement policies, and the lack of awareness of sleep apnea and its treatment are some of the major factors restraining the growth of this market. Moreover, the increasing number of competitors, the emergence of new technologies, and the potential of digital health solutions are creating opportunities for the growth of the global sleep apnea devices market.

Targeted Audience:

# health care professionals
# sleep researchers
# sleep apnea patients
# device manufacturers, suppliers, and distributors

Recent Developments:

Increasing Awareness of Sleep Apnea: Sleep apnea is increasingly becoming a topic of conversation, both in the medical field and in the public eye. This is leading to a greater awareness of the condition, which will help to increase the demand for sleep apnea devices.

Technological Advancements: Manufacturers of sleep apnea devices are continually innovating and improving their products. This includes the introduction of smarter and more efficient machines, making them easier to use and more comfortable.

FDA Approval of New Devices: The US Food and Drug Administration (FDA) has recently approved several new sleep apnea devices, including the ResMed AirFit P10 and the Philips DreamStation Go. These devices offer a more comfortable and convenient way to treat sleep apnea.

Increasing Demand for Home Sleep Tests: Home sleep tests are becoming more popular, as they are easier to administer and are more affordable than in-lab tests. This is leading to an increased demand for sleep apnea devices.

Growing Home Healthcare Market: The home healthcare market is set to grow significantly in the years to come, due to the rise in aging populations and the increasing demand for more convenient and cost-effective healthcare solutions. This is likely to drive up the demand for sleep apnea devices.

You Can Download the PDF Brochure to get Broader Outlook of This Study..!

End Users:

Based on end user, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of in the sleep apnea devices market. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR during the forecast period. This is attributed to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

Difference between Traditional Treatments for Sleep Apnea versus Treatments using Advanced Devices:

Traditional treatments for sleep apnea involve the use of lifestyle modifications and medications to reduce the severity of the condition. These treatments focus on helping to reduce the impact of sleep apnea symptoms, such as snoring and difficulty breathing during sleep. Lifestyle modifications may include weight loss, avoiding alcohol and certain medications, and avoiding sleeping on the back. Medications may include nasal decongestants, anti-inflammatory drugs, and stimulants.

Treatments using advanced sleep apnea devices involve the use of specialized equipment to help manage the condition. These devices are designed to help keep the airway open during sleep, allowing the patient to breathe more easily. They may include continuous positive airway pressure (CPAP) devices, mandibular advancement devices (MADs), or a combination of the two. CPAP devices deliver a steady stream of air through a mask that is worn over the nose and/or mouth during sleep. MADs are mouthpieces that are worn during sleep to help keep the jaw forward, opening the airway and allowing for easier breathing.

Read the Detailed Report on “Global Sleep Apnea Devices Industry Growth Dynamics - 2026”, Here..!

Sleep Apnea Devices Market Trends, Challenges & Opportunities - 2026

 Overview of This Study:

This study involved four major activities in estimating the current size of the sleep apnea devices market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sleep apnea devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and market have been identified through extensive secondary research
# The revenues generated from the sleep apnea devices business of leading players have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Projected Surge in Revenue Generation:

The global Sleep Apnea Devices Market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

DRIVER: Large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea devices market

The massive pool of undiagnosed patients of sleep apnea holds tremendous potential for the global market. It is expected with the ongoing awareness campaigns and efforts, the untouched patients base would be diagnosed and treated for the sleep apnea. The increasing trend of oral appliances and home sleep care for the management of sleep apnea are pushing the growth of the market. Over past few years, there is an increasing number of companies venturing into the sleep apnea market.

RESTRAINT: The high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls

The high expenses of the CPAP machines are burden to the patients of sleep apnea, the expenses of these machines are sparsely covered by Medicare in the US, while other countries don’t cover any cost of CPAP. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy creates a huge hurdle for patients.

Recent Developments:

# In June 2021, Oventus Medical signed a partnership agreement with Aeroflow Healthcare to provide Oventus’ obstructive sleep apnea (OSA) treatment solutions, including O2Vent Optima, directly to consumers via sleep clinics in the US.

# In February 2021, Oventus Medical launched 02Vent Optima, a customizable oral appliance therapy device that offers an alternative to CPAP therapy in the US through GoPAPfree.

# In November 2020, Panthera Dental collaborated with Dentsply Sirona.

# In December 2019, Fisher & Paykel Healthcare signed a USD-1.5-million partnership agreement with Counties Manukau Health (CM Health) to provide funding for clinical research at Middlemore Hospital.

# In March 2019, ResMed acquired HB Healthcare, a home medical equipment provider, which offers sleep and respiratory care devices.

OPPORTUNITY: Growing demand for home sleep apnea tests (HSATs), and increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence

People are opting more for the home sleep apnea tests (HSATs) due to their affordability and comfort of sleep apnea management at home. The telemedicine has witnessed a surge in the demand maid the pandemic. The incoming advanced technologies in the domain of sleep apnea devices such as Artificial Intelligence (AI) are also creating more opportunities for the market.

CHALLENGES: Lack of patient compliance

The lack of patient compliance to CPAP therapy is a challenging aspect in the growth of the market. Treatment compliance, especially of the CPAP, has always been an issue with sleep apnea patients. This is mainly due to the lack of affordability and comfort.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

End Users:

Sleep laboratories & hospitals account for the largest share of the sleep apnea devices market. The home care settings/individuals’ segment is expected to grow at the fastest pace during the forecast period.

Based on end user, the market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of in themarket in 2020. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR from 2021 to 2026, owing to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

Geographical Growth Dynamics:

North America was the largest regional market for sleep apnea devices market in 2020.

The sleep apnea devices market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America was the largest regional segment of the overall market, followed by Europe. The large share of North American can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and the of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

Key Market Players:

The prominent players operating in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

You Can Also Request for the New Version of This Report@ https://www.marketsandmarkets.com/RequestNewVersion.asp?id=719

Read More Details on Related Topics:

# Respiratory Care Devices Market - Global Forecast to 2026

# Patient Monitoring Devices Market - Global Forecast to 2027

# Home Healthcare Market - Global Forecast to 2026

# Pulse Oximeter Market - Global Forecast to 2027

Sleep Apnea Devices Market - Major Growth Influencing Factors

Global Sleep Apnea Devices Market Dynamics:

DRIVER: Large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, and an increasing number of companies venturing into the sleep apnea market

The massive pool of undiagnosed patients of sleep apnea holds tremendous potential for the sleep apnea devices market. It is expected with the ongoing awareness campaigns and efforts, the untouched patients base would be diagnosed and treated for the sleep apnea. The increasing trend of oral appliances and home sleep care for the management of sleep apnea are pushing the growth of the market. Over past few years, there is an increasing number of companies venturing into the sleep apnea market.

Projected Growth in Revenue Generation:

The sleep apnea treatment market is projected to reach USD 9.9 billion by 2026 from USD 7.1 billion in 2021, at a CAGR of 6.9% during the forecast period.

RESTRAINT: The high cost of CPAP machines, complex referral pathways, long waiting periods, and product recalls

The high expenses of the CPAP machines are burden to the patients of sleep apnea, the expenses of these machines are sparsely covered by Medicare in the US, while other countries don’t cover any cost of CPAP. The medical visits to multiple locations, the inconvenient and high cost of diagnosis, and therapy creates a huge hurdle for patients.

OPPORTUNITY: Growing demand for home sleep apnea tests (HSATs), and increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence

People are opting more for the home sleep apnea tests (HSATs) due to their affordability and comfort of sleep apnea management at home. The telemedicine has witnessed a surge in the demand maid the pandemic. The incoming advanced technologies in the domain of sleep apnea devices such as Artificial Intelligence (AI) are also creating more opportunities for the market.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

COVID-19 impact on the sleep apnea devices market

The growth of the sleep apnea devices market has massively increased due to the sudden outbreak of the COVID-19 pandemic. In the first quarter of 2020, companies faced certain operational and logistic challenges due to the imposition of nationwide lockdowns. However, eventually, the massive influx of COVID-19 patients and the adverse impact of the virus on sleep apnea patients led to a rise in the demand for and production of sleep apnea devices, such as PAP devices, masks, and sleep ventilators.

Lockdowns in nations across the globe increased the adoption of home sleep apnea tests (HSATs) over PSG devices. Telemedicine and teleconsultations also gained popularity during the pandemic, which further supported the growth of the market. However, with the launch of various COVID-19 vaccines, it can be expected that the incidence of COVID-19 will decline gradually, and the market will continue to grow at a normal pace in the coming five years.

Sleep laboratories & hospitals account for the largest share of the Sleep Apnea Treatment Market in 2020. The home care settings/individuals’ segment is expected to grow at the fastest rate during the forecast period.

Based on end users, the sleep apnea devices market is segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment accounted for the largest share of the sleep apnea devices market in 2020. However, the home care settings/individuals’ segment is estimated to grow at the highest CAGR during the forecast period. This is attributed to the increasing preference for home sleep testing by both patients and insurance companies, coupled with the favourable reimbursement scenario for home sleep testing.

North America was the largest regional market for the Sleep Apnea Treatment Market in 2020

The Sleep Apnea Devices Market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and Rest of the world (Latin America, and the Middle East & Africa). North America was the largest regional market for Sleep Apnea Devices Market in 2020. The large share of the North American market can be attributed to the increasing prevalence of the sleep apnea, growing awareness, wide usage of oral appliances for sleep apnea and of the leading players, such as ResMed, and Inspire Medical Systems, Inc., in the region.

However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Emerging APAC economies such as Japan, Australia and China are expected to see significant growth due the increasing prevalence of sleep apnea, the presence of a large undiagnosed patient pool in countries such as India, strategic agreements between global market leaders and regional players, and initiatives undertaken by governments and other private organizations to raise awareness on sleep disorders in several Asia Pacific countries are driving the market for sleep apnea devices in the region.

Key Players:

The global Sleep Apnea Treatment Market is consolidated. The prominent players operating in this market include ResMed (US), Koninklijke Philips N.V. (Netherlands), and Fisher & Paykel Healthcare (New Zealand).

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=719

Key Strategies Adopted by Players in the Sleep Apnea Devices Market for Global Growth

The Sleep Apnea Devices Market is projected to reach USD 6.49 Billion by 2023 from an estimated USD 4.44 Billion in 2018, at a CAGR of 7.8%. 

The sleep apnea devices market is dominated by a few players globally. Players in this market compete with each other to deliver superior quality therapeutic and diagnostic products for OSA (Obstructive Sleep Apnea). In 2017, the sleep apnea devices market was dominated by a few large players, namely, ResMed, Inc. (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand).

Product launches, product approvals, acquisitions, agreements, and contracts were the key strategies adopted by players between 2015 and 2018.

Download the PDF Brochure for More Details@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719

ResMed dominated the sleep apnea devices market in 2017. The company gained a major share in the sleep apnea devices market on account of its diversified product portfolio, widespread geographical presence, and focus on strategies such as innovation and expansions. The company strongly focuses on expansion into new product segments as well as geographies to gain a competitive edge in the market. 

Thus, to enter the high growth market, ResMed acquired Laboratoires Narval, S.A. (France) to supply custom-made mandibular advancement devices. Additionally, in February 2016, ResMed acquired Brightree LLC (US), a provider of cloud-based software solutions for the post-acute care industry. This acquisition strengthened ResMed’s market position as well as significantly expanded its software product portfolio. ResMed also has a strong patent portfolio which helps the company maintain its leadering position in the market.

Koninklijke Philips is the second largest player in the global sleep apnea devices market. The company’s strong position in this market can be attributed to its acquisition of Respironics in 2008, a US-based established manufacturer and distributor of sleep and respiratory products. The company’s wide geographical presence and strong distribution network have also helped it to gain a significant market share. In the past three years, innovation has been the company’s core business strategy to increase its share in the global sleep apnea devices market. 

This strategy is largely supported by the company’s strong R&D activities. The company invested USD 455.91 million (5.8% of its Personal Health segment sales) in R&D in 2017. The company’s rich pool of skilled R&D personnel ensures constant development and launch of technologically advanced products in the market. This further helps Philips to launch products like masks, PAP devices, and ventilators in the market.

Fisher & Paykel Healthcare accounted for the third largest share of the global sleep apnea devices market. The company strongly focuses on developing and establishing a direct sales force in major geographic markets. The company significantly invests in R&D activities to launch technologically advanced products in the market. The company’s rich pool of skilled R&D personnel ensures constant development and launch of advanced products in the market. 

It invested USD 59.94 million, USD 51.29 million, and USD 53.98 million in R&D in 2017, 2016, and 2015, respectively. As a result of its strong R&D activities, the company has launched sleep apnea products like nasal pillow masks, optiflow nasal cannulas, and Airspiral tubes. The growing workforce, strong R&D, and consistent new product launches are likely to help the company gain a greater market share in the coming years.

You Can Also Talk to Our Research Experts to Get More Detailed Information

Other players in the sleep apnea devices market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Löwenstein Medical GmbH & Co. KG. (Germany), Whole You, Inc. (US), BMC Medical Co., Ltd. (China), Drive DeVilbiss Healthcare (US), and Braebon Medical Corporation (Canada).

Target Audience:

• Medical devices manufacturing companies
• Medical devices suppliers and distributors
• Diagnostic laboratories
• Hospitals
• Venture capitalists
• Sleep laboratories
• Business research and consulting service providers

Scope of the Report:

The research report categorizes the sleep apnea devices market into the following segments and sub-segments:

Sleep Apnea Devices Market, By Type

• Therapeutic Devices:
  • Positive Airway Pressure (PAP) Devices
    • APAP
    • CPAP
    • BPAP
  • Facial Interfaces
    • Masks
      • Full-face masks
      • Nasal Pillow Masks
      • Nasal Masks
    • Cushions
  • Adaptive Servo-Ventilation (ASV)
  • Accessories
    • Mandibular Advancement Devices
    • Tongue-retaining Devices
  • Oral Appliances
    • Chin Restraints
    • Other Accessories
  • Other Therapeutic Devices
• Diagnostic Devices
  • Polysomnography (PSG) Devices
    • Clinical PSG Devices
    • Ambulatory PSG Devices
  • Home Sleep Testing Devices
  • Oximeters
    • Fingertip Oximeters
    • Handheld Oximeters
    • Wrist-worn Oximeters
    • Tabletop Oximeters
  • Actigraphy Systems
  • Sleep Screening Devices

Sleep Apnea Devices Market, By End User

• Sleep Laboratories & Hospitals
• Home Care/Individuals

Sleep Apnea Devices Market, By Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
•  APAC
  • Japan
  • China
  • Australia
  • Rest of Asia Pacific (RoAPAC)
• Rest of the World

Read More@ 
https://www.marketsandmarkets.com/Market-Reports/sleep-apnea-devices-market-719.html